Mussini Cristina
Ruolo/Qualifica | Professore Straordinario |
---|---|
Anno/Semestre | A2-S1 |
Studio | Clinica delle Malattie Infettive, Policlinico, via del Pozzo 71, Modena |
Telefono | +39 059 4222466 |
crimuss@unimore.it | |
Ricevimento | Dal lunedì al venerdì, previo appuntamento via e-mail |
Corso integrato | Infermieristica in area medica |
Modulo didattico | Infettivologia |
Breve curriculum vitae
Interessi di ricerca
- Infezione da HIV (epidemiologia, terapia, infezioni opportunistiche) - Infezioni batteriche (sepsi da germi multiresistenti)
Cinque pubblicazioni e/o tesi di laurea in Infermieristica
Cossarizza A, Bertoncelli L, Nemes E, Lugli E, Pinti M, Nasi M, De Biasi S, Gibellini L, Montagna JP, Vecchia M, Manzini L, Meschiari M, Borghi V, Guaraldi G, Mussini C. T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. PLoS One. 2012;7(12):e50728. doi: 10.1371 Impact Factor: 4,411 Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, Magnani G, Pinti M, Lopalco L, Mussini C, Ruotolo R, Galli M, Cossarizza A, Casoli C. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood. 2012 Jun 28;119(26):6259-67. Impact Factor: 9,898 Castagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, Garcia F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Fabre-Colin C, Kjaer J, Grarup J, Costagliola D, Lodwick R, Ledergerber B, Phillips A. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. Lancet Infect Dis. 2012 Feb;12(2):119-27. Impact Factor: 17,391 Nemes E, Lugli E, Bertoncelli L, Nasi M, Pinti M, Manzini S, Prati F, Manzini L, Del Giovane C, D'Amico R, Cossarizza A, Mussini C. CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. AIDS. 2011 Jul 31;25(12):1443-53. Impact Factor: 6,245 Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN.Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 2010 Jul 31;376(9738):340-5. Impact Factor: 33,633